Health Care & Hospital Law,
Civil Litigation
Sep. 2, 2021
Some plaintiffs are asking if $26B opioid settlement is enough
The deal would have Johnson & Johnson pay $5 billion and three major drug distributors pay $21 billion over the next 18 years to settle allegations they contributed to the crisis.
With a $26 billion nationwide opioid settlement hanging in the balance, cities and counties engaged in litigation are questioning whether the deal adequately compensates them for the costs they incurred suing drug companies for allegedly fueling the opioid crisis.
The deal would have Johnson & Johnson pay $5 billion and three major drug distributors pay $21 billion over the next 18 years to settle allegations they contributed to the cr...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Government, Civil Litigation, Bankruptcy
California to appeal Purdue Pharma settlement
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
$52B opioid trial ends with tense attorney-judge exchange
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Challenge to pharmacy’s opioid control is dismissed
By Winston Cho
Health Care & Hospital Law
Body brokers unlawfully profit off of vulnerable members of society
By Doug Rochen
Law Practice, Judges and Judiciary, Health Care & Hospital Law
Will courts mandate jurors receive COVID vaccines?
By Malcolm Maclachlan
Health Care & Hospital Law, Civil Litigation
6 states not yet in national opioid settlement
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Plaintiffs urge all states to agree to $26B opioid deal, California case nears end
By Blaise Scemama
